Seattle, WA, United States of America

Matthew N Idso

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew N Idso

Introduction

Matthew N Idso is a notable inventor based in Seattle, WA. He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Idso's work focuses on developing advanced immunostimulants that target specific pathogens.

Latest Patents

Idso's latest patents include the development of SARS-CoV-2 epitope-targeted peptide immunostimulants. These patents disclose compounds, compositions, and methods related to epitope-targeted immunostimulants (EPIs). The EPIs consist of a synthetic peptide ligand that binds to an epitope on a target, along with an antibody-recruiting moiety that facilitates the recruitment of antibodies to the target. The methods outlined in these patents aim to stimulate an immune reaction to microorganisms or other pathogens in subjects, utilizing multi-omic analysis to identify the peptide ligand.

Career Highlights

Throughout his career, Idso has worked with prominent organizations, including the Institute for Systems Biology and the U.S. Government as represented by the Secretary of the Army. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of immunology.

Collaborations

Idso has collaborated with esteemed colleagues such as James R. Heath and Mario Arrieta-Ortiz. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Matthew N Idso's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in immunostimulant technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…